ANTX
Price
$1.05
Change
-$0.00 (-0.00%)
Updated
Aug 14 closing price
Capitalization
28.83M
83 days until earnings call
PHRRF
Price
$0.33
Change
+$0.05 (+17.86%)
Updated
Aug 14 closing price
Capitalization
28.93M
Interact to see
Advertisement

ANTX vs PHRRF

Header iconANTX vs PHRRF Comparison
Open Charts ANTX vs PHRRFBanner chart's image
AN2 Therapeutics
Price$1.05
Change-$0.00 (-0.00%)
Volume$73.99K
Capitalization28.83M
PharmaTher Holdings
Price$0.33
Change+$0.05 (+17.86%)
Volume$1.65M
Capitalization28.93M
ANTX vs PHRRF Comparison Chart in %
Loading...
ANTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PHRRF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ANTX vs. PHRRF commentary
Aug 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANTX is a Hold and PHRRF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 15, 2025
Stock price -- (ANTX: $1.05 vs. PHRRF: $0.33)
Brand notoriety: ANTX and PHRRF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ANTX: 46% vs. PHRRF: 210%
Market capitalization -- ANTX: $28.83M vs. PHRRF: $28.93M
ANTX [@Biotechnology] is valued at $28.83M. PHRRF’s [@Biotechnology] market capitalization is $28.93M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.07B to $0. The average market capitalization across the [@Biotechnology] industry is $1.85B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANTX’s FA Score shows that 1 FA rating(s) are green whilePHRRF’s FA Score has 0 green FA rating(s).

  • ANTX’s FA Score: 1 green, 4 red.
  • PHRRF’s FA Score: 0 green, 5 red.
According to our system of comparison, ANTX is a better buy in the long-term than PHRRF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANTX’s TA Score shows that 2 TA indicator(s) are bullish while PHRRF’s TA Score has 4 bullish TA indicator(s).

  • ANTX’s TA Score: 2 bullish, 6 bearish.
  • PHRRF’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, PHRRF is a better buy in the short-term than ANTX.

Price Growth

ANTX (@Biotechnology) experienced а -2.31% price change this week, while PHRRF (@Biotechnology) price change was -15.38% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.69%. For the same industry, the average monthly price growth was +27.47%, and the average quarterly price growth was +19.86%.

Reported Earning Dates

ANTX is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+7.69% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PHRRF($28.9M) and ANTX($28.8M) have the same market capitalization . PHRRF YTD gains are higher at: 103.453 vs. ANTX (-23.551). ANTX has more cash in the bank: 67.1M vs. PHRRF (1.29M).
ANTXPHRRFANTX / PHRRF
Capitalization28.8M28.9M100%
EBITDA-47.8MN/A-
Gain YTD-23.551103.453-23%
P/E RatioN/AN/A-
Revenue0N/A-
Total Cash67.1M1.29M5,193%
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
ANTX: Fundamental Ratings
ANTX
OUTLOOK RATING
1..100
17
VALUATION
overvalued / fair valued / undervalued
1..100
10
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
60
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ANTXPHRRF
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 8 days ago
84%
Bullish Trend 10 days ago
88%
Declines
ODDS (%)
Bearish Trend 15 days ago
84%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
71%
Bullish Trend 1 day ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
ANTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PHRRF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GALT3.760.09
+2.45%
Galectin Therapeutics
PNC194.571.17
+0.60%
PNC Financial Services Group
MZTI181.36-1.69
-0.92%
The Marzetti Company
SYRE16.86-0.54
-3.10%
Spyre Therapeutics
RNTX1.15-0.04
-3.75%
Rein Therapeutics Inc

ANTX and

Correlation & Price change

A.I.dvisor tells us that ANTX and PHAR have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ANTX and PHAR's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANTX
1D Price
Change %
ANTX100%
+0.48%
PHAR - ANTX
28%
Poorly correlated
+1.16%
ATNM - ANTX
27%
Poorly correlated
+3.12%
NKTX - ANTX
26%
Poorly correlated
-0.45%
CSLLY - ANTX
26%
Poorly correlated
-1.23%
ZVRA - ANTX
26%
Poorly correlated
-5.62%
More

PHRRF and

Correlation & Price change

A.I.dvisor tells us that PHRRF and HOTH have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PHRRF and HOTH's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PHRRF
1D Price
Change %
PHRRF100%
+19.31%
HOTH - PHRRF
24%
Poorly correlated
-0.77%
RLYB - PHRRF
20%
Poorly correlated
+1.98%
INNMF - PHRRF
20%
Poorly correlated
N/A
ANTX - PHRRF
20%
Poorly correlated
+0.48%
KMSTF - PHRRF
13%
Poorly correlated
N/A
More